Bg pattern

SODIUM MONOPHOSPHATE 1M FRESENIUS KABI 120 MG/ML CONCENTRATE FOR PERFUSION SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use SODIUM MONOPHOSPHATE 1M FRESENIUS KABI 120 MG/ML CONCENTRATE FOR PERFUSION SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show translation

Introducción

PROSPECTO: INFORMACIÓN PARA EL USUARIO

Fosfato monosódico 1M Fresenius Kabi 120 mg/ml concentrado para solución para perfusión

Fosfato monosódico

Lea todo el prospecto detenidamente antes de empezar a usar el medicamento.

  • Conserve este prospecto, ya que puede tener que volver a leerlo.
  • Si tiene alguna duda, consulte a su médico o farmacéutico.
  • Este medicamento se le ha recetado solamente a usted y no debe dárselo a otras personas, aunque tengan los mismos síntomas, ya que puede perjudicarles.
  • Si experimenta efectos, consulte a su médico incluso si se trata de efectos adversos que no aparecen en este prospecto Ver sección 4.

Contenido del prospecto:

  1. Qué es Fosfato monosódico 1M Fresenius Kabi y para qué se utiliza
  2. Qué necesita saber antes de usar Fosfato monosódico 1M Fresenius Kabi
  3. Cómo usar Fosfato monosódico 1M Fresenius Kabi
  4. Posibles efectos adversos
  5. Conservación de Fosfato monosódico 1M Fresenius Kabi
  6. Contenido del envase e información adicional

1. Qué es Fosfato monosódico 1M Fresenius Kabi y para qué se utiliza

Fosfato monosódico 1M Fresenius Kabi es un medicamento que pertenece a un grupo llamado soluciones de electrolitos.

Se utiliza para la reposición de fosfatos en situaciones clínicas de hipofosfatemia.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. Qué necesita saber antes de usar Fosfato monosódico 1M Fresenius Kabi

No useFosfato monosódico 1M Fresenius Kabi

  • si es alérgico (hipersensible) al fosfato monosódico o a cualquiera de los demás componentes de Fosfato monosódico 1M Fresenius Kabi.
  • si padece de enfermedad grave de riñón.
  • si le han detectado niveles altos de fosfato en sangre.
  • si padece de episodios, que cursan con infección, de cálculos en el riñón de fosfatos de amonio y magnesio.
  • si padece de infecciones en el riñón, provocadas por microorganismos que hidrolizan la urea.
  • si sigue una dieta baja en sodio.

Advertencias y precauciones

Antes de iniciar el tratamiento con Fosfato monosódico 1M Fresenius Kabi, su médico debe tener especial precaución y valorar la administración o no de este medicamento:

  • si tiene niveles altos de fosfatos, niveles altos de sodio o niveles bajos de calcio.
  • si padece de problemas con su corazón, hígado o riñón.
  • si padece de tensión arterial alta.
  • si padece de tensión arterial alta durante el embarazo.
  • si padece de acumulación de líquidos en su cuerpo o en sus pulmones.

Uso de otros medicamentos

Informe a su médico o farmacéutico si está utilizando o ha utilizado recientemente otros medicamentos, incluso los adquiridos sin receta.

La administración simultánea de este medicamento con otros que contienen sodio puede favorecer la acumulación de líquido en su cuerpo.

Su utilización con medicamentos que contienen calcio, incluyendo suplementos dietéticos y antiácidos, puede aumentar el riesgo de acumulación de calcio en algún tejido de su cuerpo.

No debe usarse simultáneamente con otros medicamentos que contengan fosfatos.

Uso deFosfato monosódico 1M Fresenius Kabicon los alimentos y bebidas

No se conoce interacción con alimentos y bebidas.

Embarazo y lactancia

Consulte a su médico o farmacéutico antes de utilizar cualquier medicamento.

Conducción y uso de máquinas

Fosfato monosódico 1M Fresenius Kabi no afecta a la capacidad para conducir o utilizar máquinas.

3. Cómo usar Fosfato monosódico 1M Fresenius Kabi

Siga exactamente las instrucciones de administración de Fosfato monosódico 1M Fresenius Kabi indicadas por su médico. Consulte a su médico o farmacéutico si tiene dudas.

Fosfato monosódico 1M Fresenius Kabi le será administrado siempre bajo la supervisión directa de su médico, quien controlará muy de cerca la dosis administrada.

Fosfato monosódico 1M Fresenius Kabi se administra mediante inyección lenta en una vena (perfusión intravenosa). La velocidad así como la cantidad administrada dependerá de sus necesidades y del trastorno a tratar, teniendo en cuenta la dosis máxima diaria recomendada.

Su médico decidirá qué dosis administrarle.

Uso en niños

La dosis normal en niños es de 1,5 a 2 mmol/kg/día.

Si usa másFosfato monosódico 1M Fresenius Kabidel que debe

Si usted recibe más Fosfato monosódico 1M Fresenius Kabi del que debiera, sus niveles de fosfato y sodio en sangre se pueden elevar.

Su médico debe asegurarse de que usted recibe la cantidad correcta de Fosfato monosódico 1M Fresenius Kabi. En caso de que la dosis sea demasiado alta para usted, su médico detendrá inmediatamente su administración y le administrará un tratamiento apropiado.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Posibles efectos adversos

Al igual que todos los medicamentos, Fosfato monosódico 1M Fresenius Kabi puede producir efectos adversos, aunque no todas las personas los sufran.

Si considera que alguno de los efectos adversos que sufre es grave o si aprecia cualquier efecto adverso no mencionado en este prospecto, informe a su médico o farmacéutico.

En administración crónica puede haber retención de líquidos.

Si experimenta cualquier tipo de efecto adverso, consulte a su médico, farmacéutico o enfermero, incluso si se trata de posibles efectos adversos que no aparecen en este prospecto. También puede comunicarlos directamente a través del Sistema Español de Farmacovigilancia de Medicamentos de Uso Humano: https://www.notificaram.es. Mediante la comunicación de efectos adversos usted puede contribuir a proporcionar más información sobre la seguridad de este medicamento.

5. Conservación de Fosfato monosódico 1M Fresenius Kabi

No requiere condiciones especiales de conservación. Conservar en el embalaje original para protegerlo de la luz.

Mantener fuera de la vista y del alcance de los niños.

No utilice Fosfato monosódico 1M Fresenius Kabi después de la fecha de caducidad que aparece en el envase después de CAD. La fecha de caducidad es el último día del mes que se indica.

No utilice Fosfato monosódico 1M Fresenius Kabi si observa que la solución no es transparente, libre de partículas o el envase está dañado.

Los medicamentos no se deben tirar por los desagües ni a la basura. Pregunte a su farmacéutico cómo deshacerse de los envases y de los medicamentos que no necesita. De esta forma ayudará a proteger el medio ambiente.

6. Contenido del envase e información adicional

Composición deFosfato monosódico 1M Fresenius Kabi

  • El principio activo es: fosfato monosódico. Cada ml de solución contiene 120 mg de fosfato monosódico (electrolitos: Na+ 1 mmol, PO4H2 – 1 mmol).
  • Los demás componentes son: agua para preparaciones inyectables.

Aspecto del producto y contenido del envase

Fosfato monosódico 1M Fresenius Kabi es una solución para perfusión intravenosa, transparente, incolora y sin partículas visibles, contenida en ampollas de vidrio de 10 ml.

El contenido del envase es de 1 ampolla, 10 ampollas o 100 ampollas.

Titular de la autorización de comercialización y responsable de la fabricación

Titular de la autorización de comercialización

Fresenius Kabi España S.A.U.

Marina 16-18,

08005 – Barcelona

Responsable de la fabricación

Labesfal- Laboratórios Almiro, S.A.

Zona Industrial do Lagedo

3465-157 Santiago de Besteiros

Portugal

Este prospecto ha sido aprobado en Julio 2020

La información detallada y actualizada de este medicamento está disponible en la página Web de la Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) http://www.aemps.gob.es/

-----------------------------------------------------------------------------------------------------------------------

Esta información está destinada únicamente a médicos o profesionales del sector sanitario:

La administración de Fosfato monosódico 1M Fresenius Kabi es por perfusión intravenosa. El producto requiere ser diluido antes de su uso, como mínimo con una cantidad igual de diluyente.

Existen controversias sobre la administración en perfusión paralela (en Y) de fosfatos y ciprofloxacino, pues algunos autores han encontrado precipitación de ambos preparados.

Los fosfatos pueden ser incompatibles con iones metálicos como el magnesio y el calcio cuando se añaden a soluciones para nutrición parenteral.

Usar únicamente si la solución está clara.

La eliminación del medicamento no utilizado y de todos los materiales que se hayan estado en contacto con él, se realizará de acuerdo con la normativa local.

Online doctors for SODIUM MONOPHOSPHATE 1M FRESENIUS KABI 120 MG/ML CONCENTRATE FOR PERFUSION SOLUTION

Discuss questions about SODIUM MONOPHOSPHATE 1M FRESENIUS KABI 120 MG/ML CONCENTRATE FOR PERFUSION SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Camera Book a video appointment
€58
5.0 (17)
Doctor

Анастасія Шалко

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Томаш Гжеловський

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for SODIUM MONOPHOSPHATE 1M FRESENIUS KABI 120 MG/ML CONCENTRATE FOR PERFUSION SOLUTION?
SODIUM MONOPHOSPHATE 1M FRESENIUS KABI 120 MG/ML CONCENTRATE FOR PERFUSION SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in SODIUM MONOPHOSPHATE 1M FRESENIUS KABI 120 MG/ML CONCENTRATE FOR PERFUSION SOLUTION?
The active ingredient in SODIUM MONOPHOSPHATE 1M FRESENIUS KABI 120 MG/ML CONCENTRATE FOR PERFUSION SOLUTION is sodium phosphate. This information helps identify medicines with the same composition but different brand names.
Who manufactures SODIUM MONOPHOSPHATE 1M FRESENIUS KABI 120 MG/ML CONCENTRATE FOR PERFUSION SOLUTION?
SODIUM MONOPHOSPHATE 1M FRESENIUS KABI 120 MG/ML CONCENTRATE FOR PERFUSION SOLUTION is manufactured by Fresenius Kabi España, S.A.U.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of SODIUM MONOPHOSPHATE 1M FRESENIUS KABI 120 MG/ML CONCENTRATE FOR PERFUSION SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether SODIUM MONOPHOSPHATE 1M FRESENIUS KABI 120 MG/ML CONCENTRATE FOR PERFUSION SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to SODIUM MONOPHOSPHATE 1M FRESENIUS KABI 120 MG/ML CONCENTRATE FOR PERFUSION SOLUTION?
Other medicines with the same active substance (sodium phosphate) include POTASSIUM ACETATE B.BRAUN 1 mEq/ml CONCENTRATE FOR INFUSION SOLUTION, SODIUM BICARBONATE 1/6 M MEIN SOLUTION FOR INFUSION, SODIUM BICARBONATE 1M GRIFOLS INJECTABLE SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media